Publications by authors named "A Ullman"
Background: New catheter materials for peripherally inserted central catheters (PICCs) may reduce the risk of device failure due to infectious, thrombotic, and catheter occlusion events. However, data from randomized trials comparing these catheters are lacking.
Methods: We conducted a randomized, controlled, superiority trial in three Australian tertiary hospitals.
Article Synopsis
- The review emphasizes the need for equitable access to clinical trials for children from Indigenous and diverse backgrounds, which should be a priority in trial design.
- A systematic search of clinical trials conducted in Australia between 2018 and 2022 revealed that over 58% did not report important demographic variables like Indigenous status or ethnicity, highlighting significant gaps in data collection.
- The findings suggest implementing clear reporting standards and encouraging self-identification to improve demographic data collection, which is crucial for fostering health equity and safety in clinical trials involving children.
Objective: To explore current practice and guidelines surrounding the identification and management of extravasation injuries in Australian and New Zealand neonatal and pediatric settings.
Methods: Between February and September 2023, an internet-based descriptive cross-sectional survey was distributed to Australian and New Zealand neonatal and pediatric clinicians using exponential nondiscriminative snowball sampling. Survey data domains included demographics, extravasation identification, management, local guidelines, and resources.
As wearable biosensors are increasingly used in healthcare settings, this review aimed to identify the types of wearable biosensors used for neonate and pediatric patients and how these biosensors were clinically evaluated. A literature search was conducted using PubMed, CINAHL, Embase, Web of Science, and Cochrane. The studies published between January 2010 and February 2024 were included.
View Article and Find Full Text PDFPurpose: Patients receiving treatment for solid tumours and haematological malignancies, among other acute and chronic health conditions, are highly dependent upon central venous access devices (CVADs) for administering chemotherapy and other complex therapies; thus, CVADs can meaningfully impact their health outcomes and experiences. This systematic review aimed to identify and critique patient-reported outcome measure (PROM) and patient-reported experience measure (PREM) instruments related to CVADs.
Methods: A systematic review was undertaken, commencing with an electronic search of health databases (April 2022).